Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06290713 · ClinicalTrials.gov registry record · Phase 2
Vasodilator and Exercise Study for DMD (VASO-REx)
A Phase 2 study of Exercise and Duchenne Muscular Dystrophy, sponsored by University of Florida.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06290713 is a Phase 2 study of Exercise and Duchenne Muscular Dystrophy that is actively recruiting participants, run by University of Florida. The registered enrollment target is 50 participants, below the 8,910-participant average among 57 other Exercise trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06290713, a Phase 2 study of Exercise and Duchenne Muscular Dystrophy, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Examining two strategies as potential adjuvant therapies for Duchenne muscular dystrophy (DMD); aerobic exercise training (to induce adaptations in skeletal muscle and improve cardiovascular health) and tadalafil, an FDA-approved vasodilator (to optimize blood flow and muscle perfusion which is impaired and often overlooked in DMD). Target: improved muscle function, vascular health, and DMD treatment.
Conditions Studied
Interventions
- DRUG Placebo
- OTHER Exercise Training
- DRUG Tadalafil
Study Locations (1)
Florida
- University of Florida Clinical and Translational Research Building - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-06-05 |
| Est. Completion | 2026-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06290713
The ClinicalTrials.gov registry entry for NCT06290713 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 8,910-participant average among 57 other Exercise trials with a reported enrollment target (99% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Exercise appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT06290713 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06290713 about?
NCT06290713 is a clinical study titled "Vasodilator and Exercise Study for DMD (VASO-REx)". Examining two strategies as potential adjuvant therapies for Duchenne muscular dystrophy (DMD); aerobic exercise training (to induce adaptations in skeletal muscle and improve cardiovascular health) and tadalafil, an FDA-approved vasodilator (to optimize blood flow and muscle perfusion which is impa...
What is the current status of trial NCT06290713?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2024-06-05. Estimated completion is 2026-11.
What conditions does trial NCT06290713 study?
This clinical trial studies the following conditions: Exercise, Duchenne Muscular Dystrophy, Muscular Dystrophy, Vasodilation, DMD.
What interventions are being tested in trial NCT06290713?
The interventions under investigation include: Placebo (DRUG), Exercise Training (OTHER), Tadalafil (DRUG).
Who is sponsoring clinical trial NCT06290713?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06290713 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Exercise
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Response to Exercise and Nitric Oxide in PAD
RECRUITING · Phase 2
-
Fasted vs. Fed State Exercise
RECRUITING · Phase 2
-
Smart Walk: A Culturally Tailored Smartphone-Delivered Physical Activity Intervention for African American Women
RECRUITING · Phase 2
-
Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise
COMPLETED · Phase 2
-
Goal Setting to Promote Physical Activity Adherence in Midlife Adults
RECRUITING · NA
-
Better Lifestyle Counseling for African American Women During Pregnancy
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.